NCT05961865Recruiting
Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 13 Sept 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
It is a non-pharmacological (biological), spontaneous observational study. The main objective is to evaluate the correlation between inflammation markers and local adiposity, clinical risk factors and their possible variation following an AF ablation procedure
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 180 (estimated)
- First submitted
- 9 Jul 2023
- Start date
- 11 Jul 2023
- Primary completion date
- Jul 2027
- Lead sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Diseases
- Atrial fibrillation
- NCT number
- NCT05961865
What you commit to
- Study type: Observational
- Planned participants: 180
- From 11 Jul 2023 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of left auricular thrombosis on pre-procedural transesophageal echocardiogram;
- Myocardial infarction or unstable angina or recent coronary artery bypass graft (\<6 months);
- Significant co-morbidity, such as cancer, severe renal failure requiring dialysis, severe obstructive pulmonary disease, cirrhosis, with a life expectancy of less than 12 months;
Lab values
- Left ventricular ejection fraction \<30%;
Age
- Age \> 85 years or \< 18 years;
Other
- NYHA functional class IV;
- Presence of contraindications to the procedure;
- Inability to provide informed consent for study participation.
Who the study is looking for
- Paroxysmal or persistent AF;
- Patients undergoing ESC/ERAH(European Society of Cardiology/European Heart Rhythm Association) approved catheter ablation procedures;
- Aged between 18 and 85 years;
- Ability to provide informed consent for study participation.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.